Evidence map›Paper›PMID 38162084›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2023

[Construction, Identification, and Expression of

Wengui Li, Xingkun Ou, Ailin He

Open access · greenAbstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wengui Li（ 400016） Institute of Infections and Parasitic Diseases, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.
Xingkun Ou（ 400016） Institute of Infections and Parasitic Diseases, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.
Ailin He（ 400016） Institute of Infections and Parasitic Diseases, The First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China.
The Affiliated Yongchuan Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To construct Methods: Results: Examination of the recombinant plasmid by double restriction endonuclease digestion showed that the segment was of the expected length. PCR showed that 471 base pairs of Conclusion: The rLL-Eg95 vaccine was successfully constructed, expressing Eg95 protein that has specific antigenicity.

Indexed as

Echinococcus granulosusLactococcus lactisAnimalsAntigens, HelminthDNA Restriction EnzymesHelminth ProteinsMiceRecombinant ProteinsVaccines, SyntheticAntigens, HelminthDNA Restriction EnzymesHelminth ProteinsRecombinant ProteinsVaccines, SyntheticEchinococcus granulosusEg95Lactococcus lactisVaccine

Identifiers

PMID38162084
PMCPMC10752785
OpenAlexW4390507545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.